Iranian researchers develop anti-cancer nano-drug

anti cancer research
anti cancer research

Iranian researchers have developed a nano-drug which uses artificial biocompatible and biodegradable polymers to fight cancer.

Iranian researchers have developed a new anti-cancer nano-drug using artificial biocompatible and biodegradable polymers.

Mohammad Irani, a Ph.D. student in chemistry engineering at Amirkabir University of Technology and lead author of the study, said the project aims to design and build a nano-drug which increases the chemo efficiency and reduces the poisonous effects of anti-cancer drugs.

He said he and his fellow researchers have designed a nano-fiber scaffold carrying multi-walled nano-carbon pipes as drug carrier.

Using the nano-fiber scaffold carrying the Doxorubicin, the anti-cancer drug improves the treatment process and lowers the level of poison in the drug.

It takes the scaffold 30 days to get released. The anti-poison properties stay in the scaffold for three days.

An electro process method has been used to produce the nano-drug. The research also studied the way the drug is released into cancer cells in laboratories.

The results of the study have been published in Applied Polymer Science Journal.

Emad Askarieh has worked as a journalist since 2002. The main focus of his work is foreign policy and world diplomacy. He started his career at Iran Front Page Media Group, and is currently serving as the World Editor and the Vice-President for Executive Affairs at the Iran Front Page (IFP) news website.


Please enter your comment!
Please enter your name here